BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Nuance Pharma’s Ohtuvayre NDA Accepted For Review In China For COPD Maintenance Treatment

Nuance Pharma announced that the National Medical Products Administration (NMPA) of China has officially accepted for review the New Drug Application (NDA)...

January 28, 2026 | News

Corxel Pharmaceuticals Limited Secures Up To 287 Million Dollars In Series D1 Financing To Accelerate Global Cardiometabolic Pipeline

Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital Management (SR ...

January 26, 2026 | News

Crown Bioscience San Diego Laboratory Achieves CAP Accreditation Strengthening Clinical Biomarker Capabilities

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, announced that its San Diego laboratory has achieved Colle...

January 23, 2026 | News

Gene Solutions And Pangea Laboratory Partner To Advance US Clinical Validation Of Liquid Biopsy Tests

Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader ...

January 22, 2026 | News

Alteogen Signs Exclusive Global Licensing Deal With GSK Subsidiary Tesaro For ALT B4

Alteogen Inc. (KOSDAQ: 196170) announced that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK...

January 21, 2026 | News

Merck Partners With ChemLex To Accelerate Automated Chemistry And Scientific Discovery

Strategic collaboration establishes a framework to integrate automated experimentation and advanced chemistry workflows to accelerate research and discover...

January 21, 2026 | News

Telix Doses First US Patient In Phase Three BiPASS Prostate Cancer Imaging Trial

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces that the first patient in the United States (U.S.) has been dosed in BiPASS&...

January 20, 2026 | News

Harbour BioMed Strengthens Strategic Ties With Spruce Biosciences Through Equity Stake

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in imm...

January 20, 2026 | News

D3 Bio Secures FDA IND Clearances To Advance KRAS G12D And G12C Clinical Programme

D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, announced that the U.S. Foo...

January 20, 2026 | News

Dr Chris Chen Positions WuXi Biologics As The Defining Force Shaping The Future Of Global CRDMO Innovation

Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects ...

January 19, 2026 | News

GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CR...

January 19, 2026 | News

Thermo Fisher Scientific Introduces Invitrogen TaqMan Cells To CT HepatoExpress Kit For Faster Liver Based Gene Expression Analysis

Thermo Fisher Scientific has launched the Invitrogen TaqMan Cells to CT HepatoExpress Kit, a new solution designed to simplify and accele...

January 16, 2026 | News

Immunofoco CAR T Therapy IMC002 Posts Strong Responses In Advanced Gastric And Gej Cancers At Asco Gi 2026

Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from ...

January 15, 2026 | News

ElpasBio And Fosun Kairos Partner To Commercialise AlloJoin Stem Cell Therapy For Knee Osteoarthritis In Greater China

ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, announced that it has entered into a colla...

January 15, 2026 | News

Stay Connected